16.200
+1,57%
2026-10-19
Fundamental Analysis
46 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +33.5% | +35.5% | 2 / 3 | +7.6% | -6.23 pp | +1.80 pp | +9.3% | 1.04 | 6.70 | 374 | +7,6% | 49,7 | +24,4% | 6.70 | 10.49 | −36,1% |
| Pts | 8 | 8 | 8 | 0 | 0 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 16.200 (close price on 2026-10-19)EPS (TTM): 2.419
Financial charts
1.Revenue & growth
VND bn374Q2/26
1.Revenue & growth
VND bn374Q2/26
2.Profit & growth
VND bn37,3Q2/26
3.Profit mix (Penman)
VND bn201Q2/26
4.Margins & cost structure
%32.6%Q2/26
5.Returns & cash cycle
% · days9.5%Q2/26
6.Earnings quality & cash
VND bn343Q2/26
7.Asset structure
VND bn4.823Q2/26
8.Funding & debt health
VND bn · times4.823Q2/26
9.Revenue backlog
VND bn57,1Q2/26
10.Valuation
times · %7,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %592Q2/26
Adjusted EPS growth, latest quarter
53.4%
Average adjusted EPS growth, 3 quarters
55.8%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26